Evidence map›Paper›PMID 36193574›Full record

ArticleThoracic cancer2022

Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size.

Sachie Koike, Kimihiro Shimizu, Shogo Ide, Shuji Mishima, Shunichiro Matsuoka, Tetsu Takeda, Kentaro Miura, Takashi Eguchi, Kazutoshi Hamanaka, Taisuke Araki and 5 more

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Mediastinal Nodal Evaluation May Be Safely Omitted in Select Patients With Ground Glass-Dominant Lung Adenocarcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Sachie KoikeDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Kimihiro ShimizuDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.ORCID 0000-0003-4076-5174
Shogo IdeDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Shuji MishimaDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Shunichiro MatsuokaDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Tetsu TakedaDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Kentaro MiuraDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.ORCID 0000-0001-6736-4712
Takashi EguchiDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Kazutoshi HamanakaDivision of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Taisuke ArakiFirst Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan.ORCID 0000-0002-8033-868X
Kei SoneharaFirst Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan.ORCID 0000-0001-9810-4016
Keisuke TodorokiDepartment of Radiology, Shinshu University School of Medicine, Nagano, Japan.
Fumihito IchinoheDepartment of Radiology, Shinshu University School of Medicine, Nagano, Japan.
Satoshi KawakamiDepartment of Radiology, Shinshu University School of Medicine, Nagano, Japan.
Masayoshi KoinumaFaculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, Japan.
Shinshu University · JPTeikyo Heisei University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsolidation tumor ratio (CTR) calculated as the ratio of the tumor consolidation diameter to the tumor maximum diameter on thin-section computed tomography (CT) of lung cancer has been reported as an important prognostic factor. It has also been used for treatment decision-making. This study aimed to investigate the interobserver variability of CTR measurements on preoperative CT and propose a clinically useful CTR-based classification criterion.

methodsWe enrolled 119 patients who underwent surgery for suspected or diagnosed small-sized lung cancer (≤3.0 cm in diameter). Nine doctors reviewed preoperative CT scans to measure CTR. Interobserver variability of CTR measurements was evaluated using the coefficient of variation (CV) and Fleiss' κ. The prognostic effect of the CTR-based classification was assessed using the Kaplan-Meier method.

resultsInterobserver variability of CTR measurement was the highest for tumors with the lowest CTR (CTR = 0); it decreased as CTR increased and reached a plateaued level of low variability (CV <0.5) at CTR of 0.5. We proposed a three-group classification based on the findings of CTR interobserver variability (CTR < 0.5, 0.5 ≤ CTR < 1, and CTR = 1). Interobserver agreement of the judgment of the CTR-based classification was excellent (Fleiss' κ = 0.81). The classification significantly stratified patient prognosis (p < 0.001, 5-year overall survival rates with CTR < 0.5, 0.5 ≤ CTR < 1, and CTR = 1 were 100, 88, and 73.8%, respectively).

conclusionsCTR 0.5 is a clinically relevant and helpful cutoff for treatment decision-making in patients with early-stage lung cancer based on high interobserver agreement and good prognostic stratification.

Indexed as

Lung NeoplasmsHumansObserver VariationPrognosisSurvival RateTomography, X-Ray Computedconsolidation tumor ratiointerobserver variabilitylung cancer classification

Identifiers

PMID36193574
PMCPMC9626346
OpenAlexW4301392967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.